Literature DB >> 34091740

Resilience in women with primary Sjögren's syndrome.

Roberta Priori1,2, Federico Giardina3, Raffaella Izzo3, Angelica Gattamelata3, Massimo Fusconi4, Serena Colafrancesco3, Giuseppe Curcio5.   

Abstract

To assess the relationship between resilience and several diseases and individual features in primary Sjӧgren's Syndrome (SS) patients. Resilience was assessed using the Resilience Scale (RS-14). Disease activity, damage, and reported symptoms were assessed by means of ESSDAI (EULAR Sjögren's syndrome disease activity index), SSDDI (Sjӧgren's Syndrome Disease Damage Index) and ESSPRI (EULAR Sjӧgren's Syndrome Patient Reported Index). EuroQol, HADS (Hospital Anxiety and Depression Scale), SF-12 (Short-form 12 health survey), FAS (Fatigue Assessment Scale), FACIT-F (Functional Assessment of Chronic Illness Therapy - Fatigue), and IPAQ (International Physical Activity Questionnaire) questionnaires were submitted to evaluate physical and mental well-being of the recruited patients. Data about the autoimmune profile, systemic manifestations, and current therapy were collected. Educational qualifications and work activities were also considered. Descriptive, correlational, and linear regression analysis were performed. 74 consecutive women with primary SS and 74 sex and age-matched healthy subjects as a control group were recruited. SS patients displayed a moderate value of resilience (median 78.5) with no significant difference compared to controls (p = 0.38). An inverse relationship was found between resilience and mood disorders such as anxiety (p = 0.038) and depression (p < 0.001). Greater resilience was associated with a better perception of the quality of life (p = 0.02) and general health (p < 0.001), as well as with less fatigue (p = 0.008) and a more physically active lifestyle (p = 0.001). No significant relationship was found neither between resilience and age, socio-demographic and disease characteristics, nor with ESSDAI (p = 0.26), ESSPRI (p = 0.83) and SSDDI (p = 0.67). This is the first study assessing resilience in a large group of unselected primary SS patients. Most resilient primary SS patients are less depressed and show a better perception of their health. Greater resilience tends to correlate with less anxiety, physical and mental fatigue, and a more active lifestyle, while no association with disease activity and duration, damage, and socio-demographic features was detected. Considering the well-known role of resilience in helping to better cope with chronic illnesses, its assessment in SS patients should not be overlooked and the possible strategies for its improvement should be better explored and further implemented.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Fatigue Assessment Scale (FAS); Mood disorders; Resilience; Sjögren’s syndrome

Mesh:

Year:  2021        PMID: 34091740     DOI: 10.1007/s00296-021-04899-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  39 in total

1.  Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy.

Authors:  J Ciaffi; D Giuggioli; A Spinella; R Meliconi; F Ursini; C Ferri
Journal:  Scand J Rheumatol       Date:  2021-02-05       Impact factor: 3.641

2.  Factor structure and psychometric properties of the resilience scale in a spanish chronic musculoskeletal pain sample.

Authors:  Gema T Ruiz-Párraga; Alicia E López-Martínez; Lydia Gómez-Pérez
Journal:  J Pain       Date:  2012-10-12       Impact factor: 5.820

3.  Associations between resilience and sociodemographic factors and depressive symptoms in women with systemic lupus erythematosus.

Authors:  Mario García-Carrasco; Claudia Mendoza-Pinto; Julia León-Vázquez; Socorro Méndez-Martínez; Pamela Munguía-Realpozo; Ivet Etchegaray-Morales; Álvaro Montiel-Jarquín; Luis Guillermo Vázquez de Lara; Norma Edith Alonso-García; José Luis Gándara-Ramírez; Aurelio López-Colombo
Journal:  J Psychosom Res       Date:  2019-05-09       Impact factor: 3.006

4.  Resilience in women with autoimmune rheumatic diseases.

Authors:  Manuel Rojas; Yhojan Rodriguez; Yovana Pacheco; Elizabeth Zapata; Diana M Monsalve; Rubén D Mantilla; Monica Rodríguez-Jimenez; Carolina Ramírez-Santana; Nicolás Molano-González; Juan-Manuel Anaya
Journal:  Joint Bone Spine       Date:  2017-12-28       Impact factor: 4.929

Review 5.  Cytokine imbalance in patients with systemic sclerosis and resilience: the key role of interleukin-6.

Authors:  Manuel Rojas; Yhojan Rodríguez; Diana M Monsalve; Yovana Pacheco; Yeny Acosta-Ampudia; Mónica Rodríguez-Jimenez; Nicolás Molano-González; Rubén D Mantilla; Carolina Ramírez-Santana; Juan-Manuel Anaya
Journal:  Clin Exp Rheumatol       Date:  2019-01-10       Impact factor: 4.473

6.  Positive affect as a factor of resilience in the pain-negative affect relationship in patients with rheumatoid arthritis.

Authors:  Elin B Strand; Alex J Zautra; Magne Thoresen; Sigrid Ødegård; Till Uhlig; Arnstein Finset
Journal:  J Psychosom Res       Date:  2006-05       Impact factor: 3.006

7.  Resilience in systemic lupus erythematosus.

Authors:  Sílvia Fernanda Cal; Mittermayer B Santiago
Journal:  Psychol Health Med       Date:  2013-01-28       Impact factor: 2.423

8.  Vulnerability and resilience in women with arthritis: test of a two-factor model.

Authors:  Bruce W Smith; Alex J Zautra
Journal:  J Consult Clin Psychol       Date:  2008-10

9.  The impacts of resilience on the association between illness uncertainty and sleep quality among Chinese women with systemic lupus erythematosus.

Authors:  Tingting Li; Chunying Cui; Yifei Li; Lie Wang
Journal:  Clin Rheumatol       Date:  2020-01-02       Impact factor: 2.980

10.  Measurement properties of the brief resilient coping scale in patients with systemic lupus erythematosus using rasch analysis.

Authors:  José-Antonio López-Pina; Ana-Belén Meseguer-Henarejos; Juan-José Gascón-Cánovas; Dérlis-Julián Navarro-Villalba; Vaughn G Sinclair; Kenneth A Wallston
Journal:  Health Qual Life Outcomes       Date:  2016-09-13       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.